US Stock MarketDetailed Quotes

Galmed Pharmaceuticals (GLMD)

Watchlist
  • 0.5953
  • +0.0103+1.76%
Close May 13 16:00 ET
  • 0.5953
  • 0.00000.00%
Post 20:01 ET
3.93MMarket Cap-0.25P/E (TTM)

Galmed Pharmaceuticals (GLMD) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-7.40%-6.32M
-1.94%-1.95M
-72.00%-1.94M
-24.44%-1.27M
36.16%-1.17M
4.19%-5.88M
-112.47%-1.91M
48.32%-1.13M
25.46%-1.02M
-7.85%-1.83M
Net income from continuing operations
-37.14%-10.31M
-50.14%-4.82M
1.15%-1.89M
-122.97%-2.5M
13.41%-1.1M
-8.75%-7.52M
-59.18%-3.21M
-29.94%-1.91M
29.76%-1.12M
30.33%-1.28M
Operating gains losses
575.00%81K
655.56%68K
300.00%10K
214.29%22K
-2,000.00%-19K
-7.69%12K
120.45%9K
-106.10%-5K
112.28%7K
-96.88%1K
Depreciation and amortization
--0
--0
--0
--0
--0
167.74%83K
--0
--0
722.22%74K
12.50%9K
Other non cash items
-103.44%-21K
-77.01%146K
-1,300.00%-98K
-181.82%-31K
-533.33%-38K
1,400.00%611K
2,084.38%635K
-333.33%-7K
-106.96%-11K
96.59%-6K
Change In working capital
225.27%912K
183.48%490K
-109.72%-65K
782.61%628K
80.36%-141K
-651.52%-728K
-159.11%-587K
165.14%669K
-145.54%-92K
-1,894.44%-718K
-Change in receivables
225.00%240K
147.56%117K
60.14%-116K
-88.24%14K
-0.44%225K
-155.65%-192K
-184.83%-246K
32.17%-291K
-47.58%119K
-12.06%226K
-Change in payables and accrued expense
225.37%672K
209.38%373K
-94.69%51K
391.00%614K
61.23%-366K
-151.64%-536K
-148.51%-341K
260.54%960K
-744.00%-211K
-222.18%-944K
-Change in other working capital
----
----
----
----
----
113.21%7K
----
----
----
----
Cash from discontinued investing activities
Operating cash flow
-7.40%-6.32M
-1.94%-1.95M
-72.00%-1.94M
-24.68%-1.27M
36.23%-1.17M
4.19%-5.88M
-112.47%-1.91M
48.32%-1.13M
25.60%-1.02M
-7.96%-1.83M
Investing cash flow
Cash flow from continuing investing activities
-203.78%-3.38M
158.31%1.43M
99.38%-3K
-428.23%-4.57M
-153.47%-231K
-238.88%-1.11M
-207.46%-2.45M
86.25%-486K
97.45%1.39M
-68.02%432K
Net PPE purchase and sale
----
----
----
----
----
--0
----
----
----
----
Net business purchase and sale
--0
----
----
----
----
--0
--0
--0
----
----
Net investment purchase and sale
-291.99%-3.38M
164.94%1.43M
99.38%-3K
-428.23%-4.57M
-153.47%-231K
-137.43%-861K
-196.49%-2.2M
86.25%-486K
-36.87%1.39M
-68.02%432K
Net other investing changes
----
----
----
----
----
---250K
----
----
----
----
Cash from discontinued investing activities
Investing cash flow
-203.78%-3.38M
158.31%1.43M
99.38%-3K
-428.23%-4.57M
-153.47%-231K
-238.88%-1.11M
-207.46%-2.45M
86.25%-486K
97.45%1.39M
-68.02%432K
Financing cash flow
Cash flow from continuing financing activities
2.73%9.03M
165.18%1.19M
-96.53%289K
6.04M
1.51M
42.05%8.79M
448K
8.34M
0
0
Net common stock issuance
2.73%9.03M
165.18%1.19M
-96.53%289K
--6.04M
--1.51M
42.05%8.79M
--448K
--8.34M
--0
--0
Cash from discontinued financing activities
Financing cash flow
2.73%9.03M
165.18%1.19M
-96.53%289K
--6.04M
--1.51M
42.05%8.79M
--448K
--8.34M
--0
--0
Net cash flow
Beginning cash position
60.28%4.77M
-60.40%3.44M
160.20%5.09M
209.43%4.89M
60.28%4.77M
39.81%2.98M
443.64%8.68M
73.93%1.96M
-11.53%1.58M
39.81%2.98M
Current changes in cash
-136.99%-664K
117.17%671K
-124.51%-1.65M
-47.20%198K
108.30%116K
111.67%1.8M
-383.06%-3.91M
1,322.20%6.73M
156.65%375K
-306.40%-1.4M
End cash Position
-13.91%4.11M
-13.91%4.11M
-60.40%3.44M
160.20%5.09M
209.43%4.89M
60.28%4.77M
60.28%4.77M
443.64%8.68M
73.93%1.96M
-11.53%1.58M
Free cash flow
-7.40%-6.32M
-1.94%-1.95M
-72.00%-1.94M
-24.68%-1.27M
36.23%-1.17M
4.19%-5.88M
-112.47%-1.91M
48.32%-1.13M
25.60%-1.02M
-7.96%-1.83M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -7.40%-6.32M-1.94%-1.95M-72.00%-1.94M-24.44%-1.27M36.16%-1.17M4.19%-5.88M-112.47%-1.91M48.32%-1.13M25.46%-1.02M-7.85%-1.83M
Net income from continuing operations -37.14%-10.31M-50.14%-4.82M1.15%-1.89M-122.97%-2.5M13.41%-1.1M-8.75%-7.52M-59.18%-3.21M-29.94%-1.91M29.76%-1.12M30.33%-1.28M
Operating gains losses 575.00%81K655.56%68K300.00%10K214.29%22K-2,000.00%-19K-7.69%12K120.45%9K-106.10%-5K112.28%7K-96.88%1K
Depreciation and amortization --0--0--0--0--0167.74%83K--0--0722.22%74K12.50%9K
Other non cash items -103.44%-21K-77.01%146K-1,300.00%-98K-181.82%-31K-533.33%-38K1,400.00%611K2,084.38%635K-333.33%-7K-106.96%-11K96.59%-6K
Change In working capital 225.27%912K183.48%490K-109.72%-65K782.61%628K80.36%-141K-651.52%-728K-159.11%-587K165.14%669K-145.54%-92K-1,894.44%-718K
-Change in receivables 225.00%240K147.56%117K60.14%-116K-88.24%14K-0.44%225K-155.65%-192K-184.83%-246K32.17%-291K-47.58%119K-12.06%226K
-Change in payables and accrued expense 225.37%672K209.38%373K-94.69%51K391.00%614K61.23%-366K-151.64%-536K-148.51%-341K260.54%960K-744.00%-211K-222.18%-944K
-Change in other working capital --------------------113.21%7K----------------
Cash from discontinued investing activities
Operating cash flow -7.40%-6.32M-1.94%-1.95M-72.00%-1.94M-24.68%-1.27M36.23%-1.17M4.19%-5.88M-112.47%-1.91M48.32%-1.13M25.60%-1.02M-7.96%-1.83M
Investing cash flow
Cash flow from continuing investing activities -203.78%-3.38M158.31%1.43M99.38%-3K-428.23%-4.57M-153.47%-231K-238.88%-1.11M-207.46%-2.45M86.25%-486K97.45%1.39M-68.02%432K
Net PPE purchase and sale ----------------------0----------------
Net business purchase and sale --0------------------0--0--0--------
Net investment purchase and sale -291.99%-3.38M164.94%1.43M99.38%-3K-428.23%-4.57M-153.47%-231K-137.43%-861K-196.49%-2.2M86.25%-486K-36.87%1.39M-68.02%432K
Net other investing changes -----------------------250K----------------
Cash from discontinued investing activities
Investing cash flow -203.78%-3.38M158.31%1.43M99.38%-3K-428.23%-4.57M-153.47%-231K-238.88%-1.11M-207.46%-2.45M86.25%-486K97.45%1.39M-68.02%432K
Financing cash flow
Cash flow from continuing financing activities 2.73%9.03M165.18%1.19M-96.53%289K6.04M1.51M42.05%8.79M448K8.34M00
Net common stock issuance 2.73%9.03M165.18%1.19M-96.53%289K--6.04M--1.51M42.05%8.79M--448K--8.34M--0--0
Cash from discontinued financing activities
Financing cash flow 2.73%9.03M165.18%1.19M-96.53%289K--6.04M--1.51M42.05%8.79M--448K--8.34M--0--0
Net cash flow
Beginning cash position 60.28%4.77M-60.40%3.44M160.20%5.09M209.43%4.89M60.28%4.77M39.81%2.98M443.64%8.68M73.93%1.96M-11.53%1.58M39.81%2.98M
Current changes in cash -136.99%-664K117.17%671K-124.51%-1.65M-47.20%198K108.30%116K111.67%1.8M-383.06%-3.91M1,322.20%6.73M156.65%375K-306.40%-1.4M
End cash Position -13.91%4.11M-13.91%4.11M-60.40%3.44M160.20%5.09M209.43%4.89M60.28%4.77M60.28%4.77M443.64%8.68M73.93%1.96M-11.53%1.58M
Free cash flow -7.40%-6.32M-1.94%-1.95M-72.00%-1.94M-24.68%-1.27M36.23%-1.17M4.19%-5.88M-112.47%-1.91M48.32%-1.13M25.60%-1.02M-7.96%-1.83M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More